Sign Up to like & get
recommendations!
0
Published in 2019 at "Breast Cancer Research and Treatment"
DOI: 10.1007/s10549-019-05324-7
Abstract: Triple-negative breast cancers (TNBCs) represent a heterogeneous group of tumors. The lack of targeted therapies combined with the inherently aggressive nature of TNBCs results in a higher relapse rate and poorer overall survival. We evaluated…
read more here.
Keywords:
cell lines;
englerin;
sensitivity;
tnbc cell ... See more keywords
Sign Up to like & get
recommendations!
1
Published in 2017 at "Molecular Cancer Therapeutics"
DOI: 10.1158/1538-8514.synthleth-b36
Abstract: One in 8 women will develop breast cancer during the course of her life. Recent developments in the field of drug development have provided a significant increase in progression free survival and decrease in mortality…
read more here.
Keywords:
cell;
mtor;
tnbc cell;
cancer ... See more keywords
Sign Up to like & get
recommendations!
1
Published in 2022 at "AntiCancer Research"
DOI: 10.21873/anticanres.15978
Abstract: Abstract Background/Aim: We previously reported that the half maximal inhibitory concentration (IC50) values of cisplatin and epirubicin correlated in 13 triple-negative breast cancer (TNBC) cell lines between two-dimensional (2D) and three-dimensional (3D) culture methods. However,…
read more here.
Keywords:
culture;
tnbc cell;
culture methods;
tubulin isoforms ... See more keywords
Sign Up to like & get
recommendations!
1
Published in 2022 at "International Journal of Molecular Sciences"
DOI: 10.3390/ijms23073511
Abstract: Triple-negative breast cancer (TNBC) is an aggressive cancer with limited targeted therapies. RNA aptamers, suitably chemically modified, work for therapeutic purposes in the same way as antibodies. We recently generated 2′Fluoro-pyrimidines RNA-aptamers that act as…
read more here.
Keywords:
short rna;
aptamers tnbc;
tnbc cell;
optimization short ... See more keywords